Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus

The human respiratory syncytial virus (hRSV) is the main etiologic agent of severe lower respiratory tract infections that affect young children throughout the world, associated with significant morbidity and mortality, becoming a serious public health problem globally. Up to date, no licensed vacci...

Full description

Bibliographic Details
Main Authors: María José Altamirano-Lagos, Fabián E. Díaz, Miguel Andrés Mansilla, Daniela Rivera-Pérez, Daniel Soto, Jodi L. McGill, Abel E. Vasquez, Alexis M. Kalergis
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.00873/full
_version_ 1818450442645929984
author María José Altamirano-Lagos
Fabián E. Díaz
Miguel Andrés Mansilla
Daniela Rivera-Pérez
Daniel Soto
Jodi L. McGill
Abel E. Vasquez
Abel E. Vasquez
Alexis M. Kalergis
Alexis M. Kalergis
author_facet María José Altamirano-Lagos
Fabián E. Díaz
Miguel Andrés Mansilla
Daniela Rivera-Pérez
Daniel Soto
Jodi L. McGill
Abel E. Vasquez
Abel E. Vasquez
Alexis M. Kalergis
Alexis M. Kalergis
author_sort María José Altamirano-Lagos
collection DOAJ
description The human respiratory syncytial virus (hRSV) is the main etiologic agent of severe lower respiratory tract infections that affect young children throughout the world, associated with significant morbidity and mortality, becoming a serious public health problem globally. Up to date, no licensed vaccines are available to prevent severe hRSV-induced disease, and the generation of safe-effective vaccines has been a challenging task, requiring constant biomedical research aimed to overcome this ailment. Among the difficulties presented by the study of this pathogen, it arises the fact that there is no single animal model that resembles all aspects of the human pathology, which is due to the specificity that this pathogen has for the human host. Thus, for the study of hRSV, different animal models might be employed, depending on the goal of the study. Of all the existing models, the murine model has been the most frequent model of choice for biomedical studies worldwide and has been of great importance at contributing to the development and understanding of vaccines and therapies against hRSV. The most notable use of the murine model is that it is very useful as a first approach in the development of vaccines or therapies such as monoclonal antibodies, suggesting in this way the direction that research could have in other preclinical models that have higher maintenance costs and more complex requirements in its management. However, several additional different models for studying hRSV, such as other rodents, mustelids, ruminants, and non-human primates, have been explored, offering advantages over the murine model. In this review, we discuss the various applications of animal models to the study of hRSV-induced disease and the advantages and disadvantages of each model, highlighting the potential of each model to elucidate different features of the pathology caused by the hRSV infection.
first_indexed 2024-12-14T20:51:22Z
format Article
id doaj.art-efb484f2808a4c5988b81ffe676e612a
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-14T20:51:22Z
publishDate 2019-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-efb484f2808a4c5988b81ffe676e612a2022-12-21T22:47:49ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-05-011010.3389/fmicb.2019.00873426088Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial VirusMaría José Altamirano-Lagos0Fabián E. Díaz1Miguel Andrés Mansilla2Daniela Rivera-Pérez3Daniel Soto4Jodi L. McGill5Abel E. Vasquez6Abel E. Vasquez7Alexis M. Kalergis8Alexis M. Kalergis9Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, ChileSección Biotecnología, Instituto de Salud Pública de Chile, Santiago, ChileDepartment of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, United StatesSección Biotecnología, Instituto de Salud Pública de Chile, Santiago, ChileFacultad de Medicina y Ciencia, Universidad San Sebastián, Providencia, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, ChileDepartamento de Endocrinología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, ChileThe human respiratory syncytial virus (hRSV) is the main etiologic agent of severe lower respiratory tract infections that affect young children throughout the world, associated with significant morbidity and mortality, becoming a serious public health problem globally. Up to date, no licensed vaccines are available to prevent severe hRSV-induced disease, and the generation of safe-effective vaccines has been a challenging task, requiring constant biomedical research aimed to overcome this ailment. Among the difficulties presented by the study of this pathogen, it arises the fact that there is no single animal model that resembles all aspects of the human pathology, which is due to the specificity that this pathogen has for the human host. Thus, for the study of hRSV, different animal models might be employed, depending on the goal of the study. Of all the existing models, the murine model has been the most frequent model of choice for biomedical studies worldwide and has been of great importance at contributing to the development and understanding of vaccines and therapies against hRSV. The most notable use of the murine model is that it is very useful as a first approach in the development of vaccines or therapies such as monoclonal antibodies, suggesting in this way the direction that research could have in other preclinical models that have higher maintenance costs and more complex requirements in its management. However, several additional different models for studying hRSV, such as other rodents, mustelids, ruminants, and non-human primates, have been explored, offering advantages over the murine model. In this review, we discuss the various applications of animal models to the study of hRSV-induced disease and the advantages and disadvantages of each model, highlighting the potential of each model to elucidate different features of the pathology caused by the hRSV infection.https://www.frontiersin.org/article/10.3389/fmicb.2019.00873/fullhuman respiratory syncytial virusbovine respiratory syncytial viruslower respiratory tract infectionsrodent modelnon-human primate model
spellingShingle María José Altamirano-Lagos
Fabián E. Díaz
Miguel Andrés Mansilla
Daniela Rivera-Pérez
Daniel Soto
Jodi L. McGill
Abel E. Vasquez
Abel E. Vasquez
Alexis M. Kalergis
Alexis M. Kalergis
Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
Frontiers in Microbiology
human respiratory syncytial virus
bovine respiratory syncytial virus
lower respiratory tract infections
rodent model
non-human primate model
title Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
title_full Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
title_fullStr Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
title_full_unstemmed Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
title_short Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
title_sort current animal models for understanding the pathology caused by the respiratory syncytial virus
topic human respiratory syncytial virus
bovine respiratory syncytial virus
lower respiratory tract infections
rodent model
non-human primate model
url https://www.frontiersin.org/article/10.3389/fmicb.2019.00873/full
work_keys_str_mv AT mariajosealtamiranolagos currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT fabianediaz currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT miguelandresmansilla currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT danielariveraperez currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT danielsoto currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT jodilmcgill currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT abelevasquez currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT abelevasquez currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT alexismkalergis currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus
AT alexismkalergis currentanimalmodelsforunderstandingthepathologycausedbytherespiratorysyncytialvirus